Patent · US Active

Treatment of short bowel syndrome patients with colon-in-continuity

US9592274B2 · kind B2 · utility

0Cited by

6References

8Claims

0Family size

Assignee

SHIRE-NPS PHARMACEUTICALS, INC. · US

Inventors

Elizabeth L. SANGUINETTI · Salt Lake City, US
Thomas B. MARRIOTT · Sandy, US
Jennifer Lopansri · Park City, US
Consuelo M. Blosch · Seattle, US

Key dates

Filing date	Oct 5, 2016
Grant date	Mar 14, 2017
Priority date	—
Expiry date	Oct 5, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.